ASXC - asensus.com Debt to Book Capitalization Ratio

Corporate company logo of TransEnterix (ASXC)

The financial debt-to-equity ratio dynamics for Asensus Surgical, Inc. (ASXC) demonstrate a current dependence on the deployment of robots in clinics, with the indicator standing at 0.00. Business growth relies on the creation of a digital ecosystem with high customer loyalty. Development is driven by attracting leading bioengineers through stock option programs and complex R&D challenges.

Asensus Surgical Inc - ASXC Debts to Book Capitalization (period 07/04/2022 - 08/31/2024)
Flagship merchandise of Asensus Surgical Inc

For Asensus Surgical, Inc., which is developing a diversified robot-assisted surgery business, this indicator assesses the level of financial leverage. The metric compares total liabilities to the book value of equity based on daily quotes. By analyzing the capital structure trend—debt to book capitalization—the investor determines the degree of debt load. A reduction in leverage confirms stability but signals a risk of underfunding IT services and expansion into global clinics.

Competitors of Asensus Surgical, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value VERO (Venus Concept Corp)|Debts to Book Capitalization Nuwellis Corp NUWE|Debts to Book Capitalization AEMD (Aethlon Medical)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio